Skip to main content
Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
30.10
-0.63 (-2.05%)
At close: Feb 27, 2026, 4:00 PM EST
30.30
+0.20 (0.66%)
After-hours: Feb 27, 2026, 4:57 PM EST

Alkermes Revenue

In the year 2025, Alkermes had annual revenue of $1.48B, down -5.25%. Alkermes had revenue of $384.55M in the quarter ending December 31, 2025, a decrease of -10.57%.

Revenue (ttm)
$1.48B
Revenue Growth
-5.25%
P/S Ratio
3.40
Revenue / Employee
$719,951
Employees
2,050
Market Cap
5.02B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.48B-81.73M-5.25%
Dec 31, 20241.56B-105.77M-6.36%
Dec 31, 20231.66B551.61M49.61%
Dec 31, 20221.11B-61.96M-5.28%
Dec 31, 20211.17B135.00M13.00%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 10.27B
Dr. Reddy's Laboratories 3.85B
Amneal Pharmaceuticals 3.02B
Hims & Hers Health 2.35B
Lantheus Holdings 1.54B
Phibro Animal Health 1.46B
Prestige Consumer Healthcare 1.10B
BioCryst Pharmaceuticals 874.84M
Revenue Rankings

ALKS News

More News